AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10434353 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 2209407 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31350995 — Biomarker: Undetectable plasma HIV RNA
Type: Surrogate Endpoint (SUR)
Study 31282325 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 31282325 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15059505 — Biomarker: Biliary glycoprotein 1
Type: Safety Biomarker (SAF)
Genes: CEACAM1; BGP; BGP1
Study 15059505 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 15059505 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 15059505 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 11586032 — Biomarker: Placenta growth factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: PGF; PGFL; PLGF
Study 9638964 — Biomarker: Serum triglycerides
Type: Surrogate Endpoint (SUR)
Study 27453334 — Biomarker: EP300 mRNA
Type: Predictive Biomarker (PRD)
Genes: EP300; P300
Study 15447015 — Biomarker: PC mRNA
Type: Predictive Biomarker (PRD)
Genes: PC
Study 7647179 — Biomarker: EP300 mRNA
Type: Predictive Biomarker (PRD)
Genes: EP300; P300
Study 15064271 — Biomarker: DES mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: DES
Study 22435280 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 22435280 — Biomarker: SELENBP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SELENBP1; SBP
Study 22435280 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30047786 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26292291 — Biomarker: Cervical intraepithelial neoplasia
Type: Surrogate Endpoint (SUR)
Study 21716274 — Biomarker: Cytochrome P450 2C19
Type: Safety Biomarker (SAF)
Genes: CYP2C19
Study 21716274 — Biomarker: CYP1A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP1A2
Study 21716274 — Biomarker: CYP2B6 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP2B6
Study 21716274 — Biomarker: CYP2C9 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP2C9; CYP2C10
Study 21716274 — Biomarker: CYP3A5 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A5
Study 21716274 — Biomarker: P2RY12 mRNA
Type: Predictive Biomarker (PRD)
Genes: P2RY12; HORK3
Study 28558859 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10215647 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1706607 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study 24227768 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2358926 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 18925978 — Biomarker: Vitamin B12
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 20724562 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18424200 — Biomarker: Cystatin C
Type: Safety Biomarker (SAF)
Genes: CST3
Study 12540643 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30256784 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26833336 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study 12059949 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 31968351 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 31976336 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 10921014 — Biomarker: Carcinoembryonic antigen CEA
Type: Monitoring Biomarker (MOI)
Genes: CEACAM5; CEA
Study 2596940 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2596940 — Biomarker: Serum potassium
Type: Surrogate Endpoint (SUR)
Study 31345163 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 24453924 — Biomarker: CAT mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAT
Study 10826457 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2003591 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29187584 — Biomarker: Proto-oncogene c-Met
Type: Predictive Biomarker (PRD)
Genes: MET
Study 29187584 — Biomarker: Hepatocyte growth factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: HGF; HPTA
Study 24209639 — Biomarker: Coagulation factor IIa
Type: Safety Biomarker (SAF)
Genes: F2
Study 2576886 — Biomarker: SMS mRNA
Type: Predictive Biomarker (PRD)
Genes: SMS
Study 17302782 — Biomarker: EPX mRNA
Type: Predictive Biomarker (PRD)
Genes: EPX; EPER; EPO; EPP
Study 19936917 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 7839429 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 7839429 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30445461 — Biomarker: miR-423
Type: Safety Biomarker (SAF)
Genes: MIR423
Study 8456478 — Biomarker: Lactate dehydrogenase
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 2420106 — Biomarker: TRH mRNA
Type: Predictive Biomarker (PRD)
Genes: TRH
Study 25754845 — Biomarker: MBP mRNA
Type: Predictive Biomarker (PRD)
Genes: MBP
Study 18503589 — Biomarker: Complement C5
Type: Pharmacodynamic Biomarker (PDY)
Genes: C5; CPAMD4
Study 10861335 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 29524467 — Biomarker: LPP mRNA
Type: Predictive Biomarker (PRD)
Genes: LPP
Study 18602960 — Biomarker: CLSTN3 mRNA
Type: Predictive Biomarker (PRD)
Genes: CLSTN3; CS3; KIAA0726
Study 20418370 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 10567289 — Biomarker: CCS mRNA
Type: Predictive Biomarker (PRD)
Genes: CCS
Study 20837822 — Biomarker: Apolipoprotein E
Type: Predictive Biomarker (PRD)
Genes: APOE
Study 29430998 — Biomarker: GAST mRNA
Type: Predictive Biomarker (PRD)
Genes: GAST; GAS
Study 28138980 — Biomarker: SLC5A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC5A2; SGLT2
Study 21736448 — Biomarker: EPX mRNA
Type: Predictive Biomarker (PRD)
Genes: EPX; EPER; EPO; EPP
Study 16869001 — Biomarker: C-C motif chemokine 2
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CCL2; MCP1; SCYA2
Study 27159166 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 22784346 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10101924 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16518530 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 16518530 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 8400973 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3037934 — Biomarker: POMC
Type: Predictive Biomarker (PRD)
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 3037934 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29094444 — Biomarker: PIR mRNA
Type: Predictive Biomarker (PRD)
Genes: PIR
Study 24802775 — Biomarker: TPO mRNA
Type: Predictive Biomarker (PRD)
Genes: TPO
Study 24802775 — Biomarker: PC mRNA
Type: Predictive Biomarker (PRD)
Genes: PC
Study 22508732 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 18853581 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 10973843 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30259623 — Biomarker: Gastric inhibitory polypeptide
Type: Pharmacodynamic Biomarker (PDY)
Genes: GIP
Study 28845751 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23462720 — Biomarker: BRCA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: BRCA1; RNF53
Study 21289328 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study 17105757 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study 28601821 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 10736973 — Biomarker: TRH mRNA
Type: Predictive Biomarker (PRD)
Genes: TRH
Study 10736973 — Biomarker: Thyroid stimulating hormone
Type: Safety Biomarker (SAF)
Study 24801452 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20602892 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 20602892 — Biomarker: Complement C3
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: C3; CPAMD1
Study 10570638 — Biomarker: Eosinophil cationic protein
Type: Safety Biomarker (SAF)
Genes: RNASE3; ECP; RNS3
Study 2065809 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 30702996 — Biomarker: ANGPTL3 mRNA
Type: Predictive Biomarker (PRD)
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study 30702996 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 30702996 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 15008926 — Biomarker: SLA mRNA
Type: Predictive Biomarker (PRD)
Genes: SLA; SLAP; SLAP1
Study 11079508 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 31145324 — Biomarker: TTR mRNA
Type: Predictive Biomarker (PRD)
Genes: TTR; PALB
Study 11090233 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 12759722 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 12759722 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 31599955 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29914380 — Biomarker: VASP mRNA
Type: Predictive Biomarker (PRD)
Genes: VASP
Study 26181766 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16800988 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 9084325 — Biomarker: Salivary secretion
Type: Pharmacodynamic Biomarker (PDY)
Study 1679047 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7104176 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study 31434037 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 24493300 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 9672928 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26559255 — Biomarker: FASN mRNA
Type: Predictive Biomarker (PRD)
Genes: FASN; FAS
Study 25236946 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22114872 — Biomarker: SLCO1B1
Type: Safety Biomarker (SAF)
Genes: OATP-C; LST-1; OATP1B1
Study 20634634 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 20634634 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12081581 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10360856 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 31507061 — Biomarker: BRCA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: BRCA1; RNF53
Study 31507061 — Biomarker: BRCA2 mRNA
Type: Predictive Biomarker (PRD)
Genes: BRCA2; FACD; FANCD1
Study 21209230 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 19737403 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study 16288313 — Biomarker: Amyloid beta peptide (1-40)
Type: Pharmacodynamic Biomarker (PDY)
Genes: APP; A4; AD1
Study 16288313 — Biomarker: PSEN1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PSEN1; AD3; PS1; PSNL1
Study 16288313 — Biomarker: Apolipoprotein E
Type: Predictive Biomarker (PRD)
Genes: APOE
Study 24308189 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 19332193 — Biomarker: OAT mRNA
Type: Predictive Biomarker (PRD)
Genes: OAT
Study 26632754 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 26632754 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6318170 — Biomarker: BCHE
Type: Safety Biomarker (SAF)
Genes: E1
Study 21088046 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 21088046 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 21097420 — Biomarker: PIP mRNA
Type: Predictive Biomarker (PRD)
Genes: PIP; GCDFP15; GPIP4
Study 10444118 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 7774832 — Biomarker: CAP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CAP1; CAP
Study 2317911 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 7028257 — Biomarker: CAP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CAP1; CAP
Study 17509880 — Biomarker: EPX mRNA
Type: Predictive Biomarker (PRD)
Genes: EPX; EPER; EPO; EPP
Study 11810791 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 11810791 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3063286 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29531290 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29531290 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 29531290 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 27365521 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 18451643 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 12676037 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12676037 — Biomarker: Urine free cortisol
Type: Surrogate Endpoint (SUR)
Study 9175116 — Biomarker: MIP mRNA
Type: Predictive Biomarker (PRD)
Genes: MIP; AQP0
Study 9175116 — Biomarker: Macrophage inflammatory protein 1-alpha
Type: Monitoring Biomarker (MOI)
Genes: CCL3; G0S19-1; MIP1A; SCYA3
Study 15987848 — Biomarker: Urinary oxalate
Type: Surrogate Endpoint (SUR)
Study 12622584 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30267032 — Biomarker: PDCD1
Type: Safety Biomarker (SAF)
Genes: CD279; PD1; hSLE1; PD-1
Study 18001380 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 18001380 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 2563786 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21680997 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15940534 — Biomarker: REM1 mRNA
Type: Predictive Biomarker (PRD)
Genes: REM1; GES; REM
Study 30870040 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31595295 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15766818 — Biomarker: DMD mRNA
Type: Predictive Biomarker (PRD)
Genes: DMD
Study 2199681 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 2199681 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 17557777 — Biomarker: ACR mRNA
Type: Predictive Biomarker (PRD)
Genes: ACR; ACRS
Study 17557777 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 16386537 — Biomarker: von Willebrand factor
Type: Safety Biomarker (SAF)
Genes: VWF; F8VWF
Study 16386537 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 2507435 — Biomarker: PBX1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PBX1; PRL
Study 31332655 — Biomarker: PC mRNA
Type: Predictive Biomarker (PRD)
Genes: PC
Study 17369566 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 11903415 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 11903415 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3310725 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 26975947 — Biomarker: POMC
Type: Predictive Biomarker (PRD)
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 26275982 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 9039083 — Biomarker: Endothelin-1
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: EDN1
Study 3443139 — Biomarker: LCAT mRNA
Type: Predictive Biomarker (PRD)
Genes: LCAT
Study 3443139 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3443139 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 3443139 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 16162746 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 2803413 — Biomarker: MIP mRNA
Type: Predictive Biomarker (PRD)
Genes: MIP; AQP0
Study 31877968 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31877968 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 31877968 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 17725931 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15282383 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 15282383 — Biomarker: Immunoglobulin E
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 29772084 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 20593498 — Biomarker: KRAS mRNA
Type: Predictive Biomarker (PRD)
Genes: KRAS; KRAS2; RASK2
Study 27694633 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study 23165609 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 19693532 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 16887418 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 8751015 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17118092 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 26658237 — Biomarker: O-6-methylguanine-DNA-alkyltransferase
Type: Predictive Biomarker (PRD)
Genes: MGMT
Study 22293363 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 15788369 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 15788369 — Biomarker: CYP3A5 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A5
Study 15788369 — Biomarker: CYP3A7 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A7
Study 24169960 — Biomarker: LTB4R mRNA
Type: Predictive Biomarker (PRD)
Genes: LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7
Study 12760406 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 30787665 — Biomarker: PPT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PPT1; CLN1; PPT
Study 19050692 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 17215658 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17215658 — Biomarker: Serum potassium
Type: Surrogate Endpoint (SUR)
Study 14713367 — Biomarker: CYP1A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP1A2
Study 15893183 — Biomarker: NTS mRNA
Type: Predictive Biomarker (PRD)
Genes: NTS
Study 15893183 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12637127 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 21786162 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 23282127 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16954725 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9508155 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29989014 — Biomarker: Fibroblast growth factor 23
Type: Pharmacodynamic Biomarker (PDY)
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 18498919 — Biomarker: CAT mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAT
Study 18498919 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18498919 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 23349309 — Biomarker: AFF1 mRNA
Type: Predictive Biomarker (PRD)
Genes: AFF1; AF4; FEL; MLLT2; PBM1
Study 23349309 — Biomarker: CD34 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD34
Study 21315644 — Biomarker: GEM mRNA
Type: Predictive Biomarker (PRD)
Genes: GEM; KIR
Study 19827653 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30898938 — Biomarker: SLN mRNA
Type: Predictive Biomarker (PRD)
Genes: SLN
Study 12161101 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 7637157 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21052690 — Biomarker: CD14 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD14
Study 21052690 — Biomarker: Interleukin 10
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL10
Study 21052690 — Biomarker: CASP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CASP1; IL1BC; IL1BCE
Study 21052690 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 16721686 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 7572630 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 6119025 — Biomarker: GGT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GGT1; GGT
Study 31442395 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 31562049 — Biomarker: BDNF mRNA
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: BDNF
Study 31562049 — Biomarker: BDNF
Type: Safety Biomarker (SAF)
Study 31562049 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 28961832 — Biomarker: KRAS mRNA
Type: Predictive Biomarker (PRD)
Genes: KRAS; KRAS2; RASK2
Study 28961832 — Biomarker: Epidermal growth factor
Type: Monitoring Biomarker (MOI)
Genes: EGF
Study 26167086 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 26167086 — Biomarker: Serum uric acid
Type: Surrogate Endpoint (SUR)
Study 26167086 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 24506429 — Biomarker: CD14 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD14
Study 24506429 — Biomarker: RALA mRNA
Type: Predictive Biomarker (PRD)
Genes: RALA; RAL
Study 24506429 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 24506429 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 16893378 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 10385063 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 15983331 — Biomarker: GGT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GGT1; GGT
Study 19846743 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 19846743 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)